![]() ![]() In general, monitors do an acceptable job documenting in their reports the issues noted during site visits. For example, if an adverse event has been submitted to the sponsor, there is no reason to include detailed information about the event again in the monitoring report.īonus: Take the Report from Good to GREAT You also should avoid documenting details that are already on record elsewhere. Too much narrative or detailed descriptions of what was in compliance can make finding what was out of compliance more difficult. Be Sure the Report Only Includes Essential InformationĪ good clinical monitoring report should be a summary of items you reviewed during the visit-no more, no less. You should start fresh and check your work carefully when you’re finished.ĥ. Copying and pasting information from a previous report may seem like a shortcut, but it leaves too much room for error. Sloppy oversights, such as grammar mistakes and carrying over information from a previous report, can diminish confidence in your work. When a report sits incomplete for a few weeks and other visits have taken place in the meantime, the likelihood that the report will be accurate and complete is low, even with the most thorough notes.Ī great monitoring report should be clear, concise and grammatically correct. The next best practice would be to write one report before writing the next. The best-case scenario is to write the report before preparing for and going on the next visit, but this is not always possible or practical. The report should be written as soon as possible after the visit. No matter how you choose to do this, you need make note of what items require your attention after the visit to ensure nothing slips through the cracks.Įach monitor will find his or her own way of taking notes, but filling in the report during the visit is a good way to keep important issues top of mind. Although monitors always want to cross off every item on the list during a site visit, there almost always will be items that require follow-up later. Some suggested methods for keeping notes might be for you to mark off sections of the report as tasks are completed or use highlighting or another font color to show what requires assistance from the site. So many things that happen during a monitoring visit seem obvious at the time (like a follow-up item to correct a source worksheet or to re-review select data points), but in many cases, those items are forgotten soon after you leave a site. We can’t overstate the importance of taking good notes. To make sure you don’t miss an important step, you should keep the monitoring report template open throughout the visit, making note of activities as they are completed. Likewise, you should always consult the monitoring plan for the study to be sure to complete activities during the visit as required by the sponsor. In addition to site-specific preparation, you must also be sure to understand the visit report template and the purpose of each question, since these templates can vary from one sponsor to the next. Taking the time to look into these issues ahead of time will help you prioritize tasks and make the most of the time you have. What data and action items still are outstanding?Ī monitor’s time on site is often limited.Will the regulatory documents should be reviewed and what updates are needed?.Before you arrive on site, you should be able to answer the following questions: To ensure all the information will be available to write the report, you should be thoroughly prepared for the site visit. ![]() Whether you’re a monitor out in the trenches or a sponsor overseeing a study at a high level, here are a few important guidelines you and your staff should follow to ensure your clinical monitoring reports are accurate and complete.ġ. Between scheduling visits, traveling and conducting the visits, it can fall down on a monitor’s priority list. Unfortunately, this important task often doesn’t get the attention it deserves. In addition to being required by ISO and ICH guidelines, it also tells the story of the clinical trial to the FDA, demonstrating site performance and sponsor oversight during an FDA inspection. By Brandy Chittester, Chief of Clinical OperationsĪ well-written monitoring report is an essential part of documenting clinical trial oversight. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |